Business Club July 22 News Zhejiang Pharmaceutical (600216) announced that it decided to start a comprehensive shutdown and maintenance of its subordinate major production companies Xinchang Pharmaceutical Factory and Shaoxing Paojiang Vitamin Plant from the beginning of August. It is expected that the time of maintenance shutdown will be about 1 month. According to public information, Xinchang Pharmaceutical Factory mainly produces synthetic vitamin E, natural vitamin E, vitamin A, biotin, etc.; Shaoxing Paojiang vitamin plant's leading product is vitamin E. The announcement states that the overhaul does not affect the completion of the annual production plan for the main product.

In recent days, vitamin production companies have risen and overhauled. On July 16th, Guangji Pharmaceutical (000952) announced that it would suspend production and repair of the riboflavin production line, and the production stoppage time would not exceed 45 days. On July 14, Northeast Pharmaceutical (000597) announced that it would conduct major production lines for vitamin C and other products. Obsolete routine maintenance is expected to last for about 45 days. Guangji Pharmaceutical announced that the suspension of maintenance due to hot weather, increased energy consumption, is not conducive to production and energy saving.

According to industry insiders, 7-8 months is generally the period of maintenance and repair of bulk fermentation raw material medicines. On the one hand, it can avoid peak summer electricity consumption. On the other hand, leading manufacturers can take the opportunity to raise prices. CICC Research reported on July 20th that vitamin products such as VB2, VE, VA, and VB5 are expected to increase prices through suspension of production and inspection, and it is expected that Xinfu Pharmaceutical (002019) producing VB5 and Xinhe Cheng (002001) will produce VE. ) It is expected that production will be suspended in the future.